Back to search

Article

Limited cross-variant immune response from SARS-CoV-2 Omicron BA.2 in naïve but not previously infected outpatients

2022-04-10

Abstract excerpt

<h4>ABSTRACT</h4> Omicron is currently the dominant SARS-CoV-2 variant and several sublineages have emerged. Questions remain about the impact of previous SARS-CoV-2 exposure on cross-variant immune responses elicited by BA.2 infection compared to BA.1. Here we show that without previous history of COVID-19, BA.2 infection induces a reduced immune response against all variants of concern (VOC) compared to BA.1 inf...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d63d3557-e277-52e5-941c-a11d4c45eb74
DOI
10.1101/2022.04.07.22273565
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Limited cross-variant immune response from SARS-CoV-2 Omicron BA.2 in naïve but not previously infected outpatientsDOI 10.1101/2022.04.07.22273565
Select a neighboring publication to make it the new centre.